Queen Mary University Of London
Clinical trials sponsored by Queen Mary University Of London, explained in plain language.
-
Old drug, new target: can a vitamin a derivative boost pancreatic cancer treatment?
Disease control OngoingThis trial is testing if adding a repurposed drug called ATRA to standard chemotherapy (gemcitabine and nab-paclitaxel) is more effective for controlling locally advanced pancreatic cancer. About 170 patients will be randomly assigned to receive either the standard two-drug combo…
Phase: PHASE2 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for malnourished kids: antibiotics and caregiver support could cut deaths after hospital
Disease control OngoingThis large trial is testing whether adding extra support helps children survive and recover after being hospitalized for severe malnutrition. Researchers are comparing standard care against two extra packages: one gives children antibiotics to prevent infections, and the other pr…
Phase: PHASE3 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for hepatitis c patients whose first treatment failed
Disease control ENROLLING_BY_INVITATIONThis study aims to find the best second treatment for people in Pakistan whose Hepatitis C infection did not clear after their first round of antiviral drugs. It will compare two different lengths of a follow-up drug combination (12 weeks vs. 24 weeks) in about 318 adults. The go…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope for halting MS disability: drug trial aims to save crucial arm function
Disease control OngoingThis UK trial is testing whether a drug called cladribine can slow the loss of arm and hand function in people with advanced multiple sclerosis (MS). Over two years, about 200 participants will receive either the drug or a placebo to see which better protects their ability to per…
Phase: PHASE2, PHASE3 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
Sticky patch could replace painful blood tests for heart surgery recovery
Diagnosis OngoingThis study is testing a new, painless skin sensor that measures lactate levels without needles. It will be worn by 20 patients recovering from elective heart bypass or valve surgery for up to 14 hours. The goal is to see if the sensor's readings match those from standard blood te…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Diagnosis
Last updated Apr 04, 2026 02:19 UTC
-
AI tool aims to spot dangerous skin cancers before they spread
Diagnosis OngoingThis study is testing a new computer program (AI) that analyzes microscope images of skin cancer tissue. The goal is to see if the AI can accurately predict which cancers are most likely to spread to other parts of the body. Researchers are using tissue samples from 300 patients …
Sponsor: Queen Mary University of London • Aim: Diagnosis
Last updated Apr 03, 2026 14:43 UTC
-
Breakthrough test could revolutionize TB screening
Diagnosis ENROLLING_BY_INVITATIONThis study is evaluating a new blood test designed to detect the bacteria that cause dormant tuberculosis (TB) infection. Current tests can't tell if someone has been cured after treatment or identify which infected people will actually get sick. Researchers will test 250 people,…
Sponsor: Queen Mary University of London • Aim: Diagnosis
Last updated Mar 25, 2026 14:09 UTC
-
New test could cut days off dangerous heart infection diagnosis
Diagnosis OngoingThis study is testing a new blood test that reads bacterial DNA to quickly identify the specific germ causing a serious heart valve infection called infective endocarditis. The goal is to see if this new test is as accurate as the current standard method, which can take up to fiv…
Sponsor: Queen Mary University of London • Aim: Diagnosis
Last updated Mar 17, 2026 13:09 UTC
-
Could a daily bacterial pill stop infants from wheezing?
Prevention OngoingThis study is testing if a daily capsule containing bacterial proteins can prevent wheezing in infants who were recently hospitalized for severe bronchiolitis. Researchers will give the capsule or a placebo to about 173 infants for up to two years to see if it reduces the number …
Phase: PHASE2 • Sponsor: Queen Mary University of London • Aim: Prevention
Last updated Apr 02, 2026 14:57 UTC
-
Scientists dig through old records to predict prostate cancer fate
Knowledge-focused OngoingThis study analyzed medical records and tissue samples from over 3,300 men diagnosed with early-stage prostate cancer between 1990 and 2006 who chose watchful waiting (no immediate treatment). Researchers looked back at these cases to identify which factors—like PSA levels, cance…
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
New study offers At-Home HPV tests to improve screening for transgender community
Knowledge-focused OngoingThis study is exploring if self-collected samples (like vaginal swabs, urine, and mouthwash) are a good and acceptable way to check for high-risk HPV in transgender people. It aims to understand how common HPV is in this community and if self-testing could make cancer screening m…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:52 UTC